Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC

A major part of non-small cell lung cancer (NSCLC) patients treated with mono- or multimodal concept develop therapy resistance. Despite the abundance of biomarkers investigated in the past, there is still a need for valid NSCLC biomarkers. Glycodelin, an immunosuppressive endometrial protein, has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Marc A., Muley, Thomas, Weber, Rebecca, Wessels, Sabine, Thomas, Michael, Herth, Felix J. F., Kahn, Nicolas C., Eberhardt, Ralf, Winter, Hauke, Heussel, Gudula, Warth, Arne, Herold-Mende, Christel, Meister, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315759/
https://www.ncbi.nlm.nih.gov/pubmed/30518088
http://dx.doi.org/10.3390/cancers10120486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315759/
https://www.ncbi.nlm.nih.gov/pubmed/30518088
http://dx.doi.org/10.3390/cancers10120486

Ejemplares similares